N
ALBO

Nuveen’s Albireo Pharma Inc ALBO Stock Holding History

Nuveen’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,260
Closed -$870K – 3165
2022
Q4 		$870K Sell
40,260
-52,803
-57% -$1.12M ﹤0.01% 2737
2022
Q3 		$1.8M Buy
93,063
+55,774
+150% +$1.15M ﹤0.01% 2448
2022
Q2 		$741K Sell
37,289
-11,518
-24% -$304K ﹤0.01% 2909
2022
Q1 		$1.41M Sell
48,807
-4,130
-8% -$121K ﹤0.01% 2674
2021
Q4 		$1.09M Sell
52,937
-3,694
-7% -$98.2K ﹤0.01% 2833
2021
Q3 		$1.74M Buy
56,631
+473
+0.8% +$14.6K ﹤0.01% 2734
2021
Q2 		$1.98M Sell
56,158
-3,775
-6% -$123K ﹤0.01% 2717
2021
Q1 		$2.11M Sell
59,933
-88,239
-60% -$3.26M ﹤0.01% 2585
2020
Q4 		$5.56M Buy
148,172
+73,796
+99% +$2.68M ﹤0.01% 2017
2020
Q3 		$2.48M Buy
74,376
+10,927
+17% +$318K ﹤0.01% 2277
2020
Q2 		$1.68M Buy
63,449
+12,030
+23% +$284K ﹤0.01% 2412
2020
Q1 		$842K Buy
51,419
+12,952
+34% +$285K ﹤0.01% 2584
2019
Q4 		$978K Sell
38,467
-446
-1% -$8.92K ﹤0.01% 2696
2019
Q3 		$779K Buy
38,913
+1,464
+4% +$37.9K ﹤0.01% 2796
2019
Q2 		$1.21M Buy
+37,449
New +$1.25M ﹤0.01% 2657

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's ALBO Position: Q1 2023 in Review

Nuveen sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 40,260 shares — an estimated $870K sold.

Nuveen first reported a position in ALBO in Q2 2019 and held it in 15 quarters. The position peaked at $5.56M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Nuveen reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 40,260 Albireo Pharma Inc shares in Q1 2023, an estimated $870K.
  • Nuveen first reported a position in Albireo Pharma Inc in Q2 2019 and held it in 15 quarters.
  • Nuveen's Albireo Pharma Inc position peaked at $5.56M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.